Skopos Labs, Inc. Abb Vie Inc. Transaction History
Skopos Labs, Inc.
- $225 Million
- Q2 2024
A detailed history of Skopos Labs, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 10,057 shares of ABBV stock, worth $2.02 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
10,057
Previous 10,057
-0.0%
Holding current value
$2.02 Million
Previous $1.82 Billion
99.91%
% of portfolio
0.76%
Previous 0.78%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$10.4 Billion0.84% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...